"Why is keeping the product sterile so expensive? Because you've got very expensive cleanrooms and the most expensive thing is the people working in the cleanrooms. So, you have to close the system, you have to automate. You want to put the process in a box and the people outside," Caplan said. "Less people in sterile cleanrooms, closer to the patient, closed loop production -- all these reduce the cost of the product and make it affordable."
Orgenesis has partnered with hospitals to deploy its automated, closed, and flexible Orgenesis Mobile Production Units and Labs (OMPULs) for the development of CGTs. OMPULs can be rapidly deployed as a standardized industrial cleanroom alternative at or near the point of care.
Watch the video below to learn more.